Immunological biomarkers of tuberculosis

Simple item page
dc.contributor.authorWalzl G.
dc.contributor.authorRonacher K.
dc.contributor.authorHanekom W.
dc.contributor.authorScriba T.J.
dc.contributor.authorZumla A.
dc.date.accessioned2011-05-25T08:49:49Z
dc.date.available2011-05-25T08:49:49Z
dc.date.issued2011
dc.description.abstractCurrently there are no sufficiently validated biomarkers to aid the evaluation of new tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the development of more effective and shorter treatment regimens. To date, the detection of Mycobacterium tuberculosis or its products has not been able to adequately address these needs. Understanding the interplay between the host immune system and M. tuberculosis may provide a platform for the identification of suitable biomarkers, through both unbiased and targeted hypothesis-driven approaches. Here, we review immunological markers, their relation to M. tuberculosis infection stages and their potential use in the fight against tuberculosis. © 2011 Macmillan Publishers Limited. All rights reserved.
dc.description.versionReview
dc.identifier.citationNature Reviews Immunology
dc.identifier.citation11
dc.identifier.citation5
dc.identifier.citation343
dc.identifier.citation354
dc.identifier.issn14741733
dc.identifier.other10.1038/nri2960
dc.identifier.urihttp://hdl.handle.net/10019.1/14702
dc.titleImmunological biomarkers of tuberculosis
dc.typeReview
Files
Collections
Stellenbosch University - Scopus Publications